Coronavirus (COVID-19): Shared Research Data and Findings

Covid-19 resources are freely available.

Coronavirus Free Access Collection.

Cell Press is committed to handling COVID-19 papers with the same thoughtful and timely approach to peer review as is their standard. Papers that are accepted will be fast-tracked to publication, and anything published will immediately be set free on cell.com.

All resources are free to access and include guidelines for clinicians and patients. Under the 'Research' tab you will find the latest early stage and peer-reviewed research from journals including The Lancet and Cell Press, as well as a link to the Coronavirus hub on ScienceDirect, where you will find every article relevant article to Coronavirus, SARS, and MERS freely available. Under the Clinical information tab you will find resources for nurses, clinicians and patients, including FAQs on symptoms and a CDC webinar on what clinicians need to know to prepare for COVID-19 in the United States.

The JAMA Network COVID-19 collection includes Q&A's with NIAID's Anthony Fauci, an interactive map of the outbreak courtesy of The Johns Hopkins Center for Systems Science and Engineering, and past publications on vaccine development, infection control, and public health preparedness.

The Lancet has created a Coronavirus Resource Centre. This resource brings together new 2019 novel coronavirus disease (COVID-19) content from across The Lancet journals as it is published. All content listed on this page is free to access.

The journals in the Mary Ann Liebert, Inc., publishers portfolio have long served as vital, reliable, peer-reviewed resources in times where misinformation has run rampant. As the world comes to grips with the continuing COVID-19 pandemic, it is clear that there is a critical need for global preparedness, collaboration, and effective management strategies. We publish vital academic research that addresses, answers, and highlights how we can prevent and respond to global outbreaks such as that of the coronavirus, COVID-19.

Oxford University Press has made content from online resources and leading journals freely accessible to assist researchers, medical professionals, policy makers, and others who are working to address this potential health crisis.

PNAS commits to immediately and freely sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak.

Research related to coronavirus is freely available on SAGE Journals. A full list of the open articles includes research both in science, technology, and medicine and in the social and behavioral sciences. SAGE will continue to make new research available related to the virus as it is published.

Springer Nature is making SARS-CoV-2 and COVID-19 research free.

Wiley has a Covid-19: Novel Coronavirus Content Free to Access collection and is also making a collection of journal articles and book chapters on coronavirus research freely available to the global scientific community. On workdays, newly published articles are made free within 24 hours of publication. Articles published after 14:00 (EST) on Friday will be made free the following Monday.

Clarivate Analytics is offering free access to Cortellis Drug Discovery Intelligence with registration. Includes drug pipelines, disease briefings, experimental pharmacology, pharmacokinetics, animal models, targets and more.

COVID-19 resources for front-line clinicians and medical researchers, including free access to Global Infectious Diseases and Epidemiology Online Network
(GIDEON) with registration.